Julien Perrin: Presenting Thalassemia Coagulation Research at ISTH 2026
Julien Perrin, Habilitation à Diriger des Recherches, Faculté de Pharmacie – Université de Lorraine, Hématologie biologique – Responsable du secteur “Pathologies érythrocytaires”, shared a post on LinkedIn:
“It was wonderful to be back at the International Society on Thrombosis and Haemostasis (ISTH) congress in Paris after a long hiatus—and what an experience it was!
The sessions and discussions were as enriching as ever, offering plenty of leads and ideas for future work.
A highlight was the presentation of the first results from our research—co-led with Dr. Michèle Martin—on coagulation disorders in patients with thalassemia major, at CHRU de Nancy and DCAC (UMR_S 1116 INSERM-UL).
This work stems from the Master 2 projects of Dr Rémi Benoit and Dr Marie Drouilly, conducted in collaboration with Dr Jérémy Lagrange and with methodological support from Pr Nathalie THILLY.
De retour au congrès de International Society on Thrombosis and Haemostasis (ISTH) après de longues années manquées, à Paris, comment aurait-il pu en être autrement !
Des sessions et échanges toujours aussi riches, qui donnent beaucoup de pistes et d’idées pour la suite !
Avec en prime la présentation des premiers résultats de notre recherche, portée avec la Dre Michèle Martin, sur les troubles de la coagulation chez les patients porteurs de thalassémie majeure, au CHRU de Nancy et au labo DCAC (UMR_S 1116 INSERM-UL).
Résultats issus des travaux de Master 2 des Dr Rémi Benoit et Dre Marie Drouilly avec la collaboration du Dr Jérémy Lagrange et le support méthodologique du Pre Nathalie THILLY.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease